Role of Cholinergic Signaling in Alzheimer’s Disease
Open accessThe DOI matches its Crossref record; 139 of the 141 references it cites were found in a registry or an index.
Abstract
Acetylcholine, a neurotransmitter secreted by cholinergic neurons, is involved in signal transduction related to memory and learning ability. Alzheimer’s disease (AD), a progressive and commonly diagnosed neurodegenerative disease, is characterized by memory and cognitive decline and behavioral disorders. The pathogenesis of AD is complex and remains unclear, being affected by various factors. The cholinergic hypothesis is the earliest theory about the pathogenesis of AD. Cholinergic atrophy and cognitive decline are accelerated in age-related neurodegenerative diseases such as AD. In addition, abnormal central cholinergic changes can also induce abnormal phosphorylation of ttau protein, nerve cell inflammation, cell apoptosis, and other pathological phenomena, but the exact mechanism of action is still unclear. Due to the complex and unclear pathogenesis, effective methods to prevent and treat AD are unavailable, and research to explore novel therapeutic drugs is various and active in the world. This review summaries the role of cholinergic signaling and the correlation between the cholinergic signaling pathway with other risk factors in AD and provides the latest research about the efficient therapeutic drugs and treatment of AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Second-generation AChEIs, including donepezil (4), rivastigmine (5), galantamine (6), are more selective. They exhibited fewer side effects or improved pharmacokinetic profiles, establishing them as first-line drugs for AD.98,400”
From Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies. (2024) · cites this paper as [98]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“AD is a progressive neurodegenerative disorder and the leading cause of dementia among older adults, characterized by a gradual decline in cognitive function, memory loss, and behavioral changes, ultimately leading to complete dependence on caregivers [7].”
From Recent Advances in Therapeutics for the Treatment of Alzheimer’s Disease (2024) · cites this paper as [7]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Among these, neurons of the nucleus basalis of Meynert (NBM) are particularly vulnerable, and their degeneration leads to profound reductions in choline acetyltransferase (ChAT) activity within projection areas such as the cerebral cortex and hippocampus, regions essential for learning, memory, and attention [96].”
From Toward a Unified Framework in Molecular Neurobiology of Alzheimer’s Disease: Revisiting the Pathophysiological Hypotheses (2026) · cites this paper as [96]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“This hypothesis suggests that a reduction in the synthesis and release of ACh impairs its physiological functions, which are critical for learning, memory, and other cognitive processes.”
From Recent Advances in Therapeutics for the Treatment of Alzheimer’s Disease (2024) · cites this paper as [7]
The cited source says what the claim attributes to it.
In the citing paper
“The cholinergic hypothesis, one of the earliest and most influential theories of AD, proposed that the characteristic cognitive deficits of the disorder arise primarily from degeneration of cholinergic neurons in the basal forebrain [96].”
From Toward a Unified Framework in Molecular Neurobiology of Alzheimer’s Disease: Revisiting the Pathophysiological Hypotheses (2026) · cites this paper as [96]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Hafez, H. S., Ghareeb, D. A., Saleh, S. R., Abady, M. M., Demellawy, M. E., Hussien, H. M., & Abdel-Monem, N. M. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4690-x · Cited by 85
RetractedSemwal, B. C., & Garabadu, D. (2020) · NeuroMolecular Medicine · doi:10.1007/s12017-020-08615-1 · Cited by 9 · cited 2×
“Aβ can induce mitochondrial toxicity in the brain, resulting in cognitive dysfunction [5].”
BackgroundRetractedNEUROTRANSMITTER-RELATED ENZYMES AND INDICES OF HYPOXIA IN SENILE DEMENTIA AND OTHER ABIOTROPHIES
BOWEN, D. M., SMITH, C. B., WHITE, P., & DAVISON, A. N. (1976) · Brain · doi:10.1093/brain/99.3.459 · Cited by 1,311 · cited 1×
“According to clinical data in recent years, the brains of patients with AD show severe neurodegeneration and reduction of cholinergic neurons and a severe deficiency of Ach; acetylcholine transferase activity is significantly decreased, which further illustrates the damage to the cholinergic system in patients with AD…”
BackgroundEfficacy of acetylcholinesterase inhibitors in Alzheimer’s disease.
Marucci, G., Buccioni, M., Ben, D. D., Lambertucci, C., Volpini, R., & Amenta, F. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108352 · Cited by 1,147
History and progress of hypotheses and clinical trials for Alzheimer’s disease
Liu, P.-P., Xie, Y., Meng, X.-Y., & Kang, J.-S. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0063-8 · Cited by 723
Román, G. C., Jackson, R. E., Gadhia, R., Román, A. N., & Reis, J. (2019) · Revue Neurologique · doi:10.1016/j.neurol.2019.08.005 · Cited by 421
Drug candidates in clinical trials for Alzheimer’s disease
Hung, S.-Y., & Fu, W.-M. (2017) · Journal of Biomedical Science · doi:10.1186/s12929-017-0355-7 · Cited by 420
Astrogliosis: An integral player in the pathogenesis of Alzheimer's disease
Osborn, L. M., Kamphuis, W., Wadman, W. J., & Hol, E. M. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.01.001 · Cited by 312 · cited 1×
“AD is a major cause of dementia which is a common disease among the elderly, starting with an irreversible decline in episodic memory and then a more general decline in overall cognitive ability [2,3].”
BackgroundLiu, Y., Zhang, Y., Zheng, X., Fang, T., Yang, X., Luo, X., Guo, A., Newell, K. A., Huang, X.-F., & Yu, Y. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1141-5 · Cited by 285 · cited 1×
“Liposaccharide (LPS) levels are higher in the brains of Alzheimer’s patients and are associated with neuroinflammation, which is controlled by neurocholinergic signaling, and cognitive decline [81,82].”
BackgroundLuo, H., Xiang, Y., Qu, X., Liu, H., Liu, C., Li, G., Han, L., & Qin, X. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00395 · Cited by 264 · cited 1×
“Liposaccharide (LPS) levels are higher in the brains of Alzheimer’s patients and are associated with neuroinflammation, which is controlled by neurocholinergic signaling, and cognitive decline [81,82].”
Background
Research works printed but not linked: 1
- Yu, 2019, Protective roles of isoastilbin against Alzheimer’s disease via Nrf2mediated antioxidation and antiapoptosis, Int. J. Mol. Med., 43, 1406
Cited by
Items 801–900 of 1,000
Safety and effectiveness of Donepezil and Memantine in Alzheimer's Disease
Ghosh, A. (2025) · International Journal of Pharmaceutical Sciences and Drug Research · doi:10.25004/ijpsdr.2025.170310
Hoseiniyan, S. F., & Edalatmanesh, M. A. (2025) · Qur̓ān/pizhūhī-i khāvar/shināsān · doi:10.61186/iau.35.2.145
Effect of Adipokinetic Hormone on Learning-Memory in a Scopolamine-Induced Alzheimer's Model in Mice
Uyar, E., Köktürk, S., Mohammed, M. O. K., Çobanturk, P., Abuqaoud, N. A. Z., Akar, F., Ulak, G., Erden, F., & Mutlu, O. (2025) · Protein and Peptide Letters · doi:10.2174/0109298665380324250602054823
Current Understanding and Therapeutic Advances in Alzheimer’s Disease
Chen, J. (2025) · Theoretical and Natural Science · doi:10.54254/2753-8818/2025.au25268
고지방 및 고콜레스테롤 식이에 의한 비만유도에 따른 비만 마우스에서 Allium hookeri 열수 추출물의 인지기능 장애 개선 효과
문, 하., & Yun, J. (2025) · 한국식품조리과학회지 · doi:10.9724/kfcs.2025.41.3.192
Evidence of the Efficacy of Acetylcholinesterase Inhibitors in In Vivo Studies: A Systematic Review
de Souza, F. N., David, E. D. S., de Lima, H. B., Silva, A. G., Souto, R. N. P., & Hage-Melim, L. I. D. S. (2025) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/0118715273388078250801044226
Jiang, X., Lv, G., Franklin, J., Li, M., & Lu, K. (2025) · BMC Geriatrics · doi:10.1186/s12877-025-06298-6
“The ChEIs exert their action by inhibiting the enzyme cholinesterase, which in turn halts the breakdown of acetylcholine leading to increased levels of the neurotransmitter which is involved in neuron signaling related to memory and learning [6].”
Ramezannezhad, E., & Initiative, A. D. N. (2025) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823251374681
Physiological Changes Linked with Alzheimer’s Disease and Related Dementias
Payen, A., Bateman, J. R., Miller, D., Muralidhara, S. D., & Bennett, J. M. (2025) · Springer eBooks · doi:10.1007/978-3-031-73368-0_99
Carotenoids and Their Formulation Supplements in Alzheimer’s Disease
Ajayi, E. I. O., Babatunde, I. O., & Oladele, J. O. (2024) · Neuroscience Updates · doi:10.47176/update.2024.01
Detection of Aβ Aggregation by Aggregation-Induced Emission (AIE) Probes in Alzheimer’s Disease
Alam, H., & Kakhramonov, R. (2025) · Cognizance Journal of Multidisciplinary Studies · doi:10.47760/cognizance.2025.v05i08.029
Wopara, I., Adebayo, O. G., Asiwe, J. N., Ben-Chioma, A. E., Etim, O. E., Chimezie, J., Lister, O., & Amadi, B. A. (2025) · Egyptian Journal of Basic and Applied Sciences · doi:10.1080/2314808x.2025.2556502
“AChE are cholinergic system metabolism enzyme responsible for hydrolyzing acetylcholine (ACh) to choline and acetate [68] causing the reduction of ACh in the synapse at elevated levels.”
Mechanisms of Neuroprotection by Medicinal Plants and Their Phytochemicals
Kandasamy, S., & Pilla, S. P. (2025) · Springer eBooks · doi:10.1007/978-3-032-01356-9_19
Kalkan, S. K., Yıldız, E., Ozcan, E. O., Pınar, N., & Karataş, Y. (2025) · Medical Science and Discovery · doi:10.36472/msd.v12i9.1302
Althaher, A. R., Qawass, H., & Salleh, W. M. N. H. W. (2025) · Tropical Journal of Natural Product Research · doi:10.26538/tjnpr/v9i9.42
Gut–Brain axis in neurological diseases
Roy, A., Chauhan, K., Parkash, J., Yadav, M., & Iyer, M. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-29932-2.00002-5
Çınar, E. (2025) · İnönü Üniversitesi Sağlık Hizmetleri Meslek Yüksek Okulu Dergisi · doi:10.33715/inonusaglik.1642420
Histone Deacetylase Inhibition Ameliorates Oxidative Stress in Alzheimer’s Disease
Hamdy, S. M., mekheimer, M. B., Elesh, H. M. R., & El-salam, O. M. A. (2025) · Biochemistry Letters · doi:10.21608/blj.2025.410942.1077
Moyano, P. M., Flores, A., Sanjuan, J., Plaza, J. C., Guerra-Menéndez, L., Abascal, L., Sierra, O. M., & del Pino, J. (2025) · Biology · doi:10.3390/biology14101380
“BP has been reported to increase acetylcholine (ACh) levels in the adult zebrafish brain [10], which is critical for cognitive functions and cellular viability [15], and to inhibit acetylcholinesterase (AChE) activity [16], the enzyme responsible for ACh metabolism [15].”
Ashraf, A., Karnati, J., Abid, S., Tao, X., Kaghazchi, A., Wu, A., Ranganathan, S., Lunasco, L. M., Jelkin, G. L., Moon, E., et al. (2025) · The Spine Journal · doi:10.1016/j.spinee.2025.10.016
Sondh, H. K., Mueller, C., Bishara, D., & Stewart, R. J. (2025) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2025.2576102
“Acetylcholine is an important neurotransmitter which is involved in signal transfer involved in memory and learning [42].”
Rani, A., Sharma, P. B., Bhatia, S., & Sharma, A. K. (2025) · Journal of Research in Pharmacy · doi:10.12991/jrespharm.1798387
Ngxabi, S., Sogoni, A., Kerebba, N., Pieters, R., Horn, S., Giesy, J. P., Kambizi, L., Laubscher, C. P., & Jimoh, M. O. (2025) · Phytomedicine Plus · doi:10.1016/j.phyplu.2025.100908
Eastwood, J., van Hemert, S., Poveda, C. G., Elmore, S., Williams, C. M., Lamport, D. J., & Walton, G. (2025) · Journal of Applied Microbiology · doi:10.1093/jambio/lxaf272
Nascimento, L. D. A., Nascimento, É. C. M., & Martins, J. B. L. (2025) · Series in bioengineering · doi:10.1007/978-3-032-07366-2_5
Phytosterols from Rosaceae Species as Dual Modulators of Neuroinflammation and Induced Pluripotency
Alshabrmi, F. M. (2025) · Journal of Molecular Neuroscience · doi:10.1007/s12031-025-02441-5
“Further, PCA scatter analysis reveal the variance in the dataset by projecting high-dimensional data into two Chen et al. 2022 ).”
Wasim, M., Zia, S. R., Abbas, E., & Ahmad, S. (2025) · Neurochemical Journal · doi:10.1134/s1819712425700473
Polysaccharides improve cognitive impairment in mice: A meta-analysis
Wang, X.-C., Chu, C.-L., Liu, Y., Zhang, X.-Y., Chen, H.-B., & Zhang, S. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.157561
Dietary Polyphenols and the Aging Brain: Mechanistic Insights into Alzheimer’s Disease Prevention
Patel, P., Khosla, R., Garg, M., Khare, P., & Kaur, N. (2025) · Nutritional neurosciences · doi:10.1007/978-981-95-2736-6_20
Therapeutic approaches to age related cognitive decline and neurodegenerative diseases
Nandi, N. K., Singhal, A., & Tripathi, P. N. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-36295-8.00009-2
Insulin signaling in confluent diabetes and AD
Abraham, A., Gangadhara, V., & Baliga, P. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-40559-4.00008-8
Wu, H., Huang, N., Wang, K., Mi, J., Liu, Z., Wang, J., Sang, Z., & Tan, Z. (2025) · ACS Omega · doi:10.1021/acsomega.5c09187
Ajah, A. A., & Opurum, H. C. (2025) · Scholars Journal of Medical Case Reports · doi:10.36347/sjmcr.2025.v13i11.049
Jabba, H. L., Dimeji, I. Y., Ayodeji, A. S., Baba, Z. M., Adeoye, S. W., & Olawale, A. S. (2025) · Tropical Journal of Natural Product Research · doi:10.26538/tjnpr/v9i11.57
Alzheimer’s Biochemistry and Therapeutic Prospects of Functional Foods-based Strategies
Akanbi, C. A., Akanji, M. A., & Adeyemı, O. S. (2025) · The Open Biochemistry Journal · doi:10.2174/011874091x416492251129102634
Mazlan, M. K. N., Azmi, M. N., Wibowo, A., Rofiee, M. S., Bakar, M. A., Ghani, M. S. A., Omar, M. T. C., Parumasivam, T., & Mohammat, M. F. (2025) · Sains Malaysiana · doi:10.17576/jsm-2025-5411-10
Roy, A., Kumar, D., Bhattacharya, P., & Borah, A. (2025) · In Silico Pharmacology · doi:10.1007/s40203-025-00473-8
“According to clinical evidence, AD patients exhibit acute shortage of acetylcholine (ACh), diminished cholinergic activity, and significant neurode-generation (Z.-R. Chen et al. 2022a, b).”
Althaher, A. R., & Salleh, W. M. N. H. W. (2025) · Journal of Biologically Active Products from Nature · doi:10.1080/22311866.2025.2600001
“A key hallmark is the overactivity of cholinesterase enzymes, specifically AChE and BChE, which break down acetylcholine, a neurotransmitter required for learning and memory 25 .”
Cholinergic modulation of hippocampal CA1 pyramidal cell excitability in ArxGCG+7 mice
Johnson, C. M., Dong, J., Senkungu, P., Chandar, J., Ochoa-Sepulveda, N., Myers, A. J., & Marsh, E. D. (2025) · Experimental Neurology · doi:10.1016/j.expneurol.2025.115591
Yin, Q., Yuan, M., Que, F., Huang, S., & Wang, F. (2025) · Natural Product Research · doi:10.1080/14786419.2025.2591176
Current therapies for the treatment of Alzheimer's disease
Finn, L. A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-30008-0.00007-7
Inkaew, P., Sriraksa, N., Anukanon, S., Praman, S., Kamsrijai, U., Teerapattarakan, N., & Hawiset, T. (2025) · Trends in Sciences · doi:10.48048/tis.2026.11161
“Several studies have explored the beneficial effects of these bioactive compounds on cognitive enhancement and neuroprotection [35,41-43].”
Acetylcholinesterase inhibition activity and phytochemical screening of red betel leaf (
Nurinsani, E. Y. Y., Andrianto, D., & Safithri, M. (2024) · Springer Link (Chiba Institute of Technology) · doi:10.1051/bioconf/202412302009/pdf
Basolateral Amygdala Local Circuit Plasticity in Instrumental Learning Processes
Wise, E. T. (2025) · UNSWorks (University of New South Wales, Sydney, Australia) · doi:10.26190/unsworks/30813
Afolabi, O. B., Olasehinde, O. R., Owolabi, O. V., Jaiyesimi, K. F., Adewumi, F. D., Idowu, O. T., Mabayoje, S. O., Obajuluwa, A. O., & Akpor, O. B. (2024) · Figshare · doi:10.6084/m9.figshare.25495200
Mitzel, K. M. (2024) · Maryland Shared Open Access Repository (USMAI Consortium) · doi:10.13016/m2tjpw-j7sg
Jia, W., Wang, H., Li, C., Shi, J., Yong, F., & Jia, H. (2024) · Figshare · doi:10.6084/m9.figshare.26681827
Jia, W., Wang, H., Li, C., Shi, J., Yong, F., & Jia, H. (2024) · Figshare · doi:10.6084/m9.figshare.26681830
Rastegari, A., Manayi, A., Rezakazemi, M., Eftekhari, M., Khanavi, M., Akbarzadeh, T., & Saeedi, M. (2022) · Figshare · doi:10.6084/m9.figshare.21629398
Benwood, C., Walters-Shumka, J. P., Scheck, K., & Willerth, S. M. (2023) · Figshare · doi:10.6084/m9.figshare.23118946
Davidoff, H. (2024) · Lirias (KU Leuven)
Maria, C. (2022) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Tuna, A. (2023) · eArsiv - Adu (Adnan Menderes University)
Villegas Aguilar, M. D. C. (2024) · Institutional Repository of the University of Granada (University of Granada)
Inhibice vybraných enzymů hrajících roli v rozvoji neurodegenerativních onemocnění
Zachrdlová, D. (2024) · Digital library - University of Pardubice (University of Pardubice)
Investigating the Interactions of Fatty Acids, Amyloid Beta & SARS-CoV-2 Spike Protein Fragment
Toma, L. (2023) · UWSpace (University of Waterloo)
RTP801: a novel regulator of the tRNA ligase complex in Alzheimer's disease
Campoy‐Campos, G. (2024) · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya)
Črešnar, T. (2024) · Repository of the University of Ljubljana (University of Ljubljana)
Att bevara eller påverka livskvalité för personer med demenssjukdom: en litteraturstudie
Käcko, A. (2023) · Theseus (Ammattikorkeakoulujen)
Aligita, W., Suntoro, R. A., Febrina, E., Asnawi, A., & Adnyana, I. K. (2025) · Journal of Pharmacy & Pharmacognosy Research · doi:10.56499/jppres24.2271_13.s1.242
Positive Effects of Camel’s Milk for Alzheimer’s Patients
Q.B.Alenzi, F. (2025) · Journal of Carcinogenesis · doi:10.64149/j.carcinog.24.5s.284-292
Aliffia, D., Wihadmadyatami, H., Raihan, M., Kustiati, U., Sanjaya, W., Aviana, A., Nugrahaningsih, D. A. A., Widayati, W., Karnati, S., & Kusindarta, D. (2025) · Open Veterinary Journal · doi:10.5455/ovj.2025.v15.i11.27
Neuropsychological Prediction of Alzheimer’s Disease and Functional Abilities Using Brief Screeners
Bennett, A., Masey, D. P., Rosenfield, B. M., & Roberts, M. B. (2025) · Digital Commons - PCOM (Philadelphia College of Osteopathic Medicine)
Preliminary report on cholinesterase inhibition in freshwater sponges of East Java
Setiawan, E., Haula, H., & Suciati, S. (2025) · Springer Link (Chiba Institute of Technology) · doi:10.1051/bioconf/202520203012/pdf
One- and Two-Photon Excitable Photoswitchable Orthoand Allosteric Ligands of Class A GPCRs
Gerwe, H. (2025) · Online Publication Service of Würzburg University (Würzburg University) · doi:10.25972/opus-34870
Vayalapalli, A., Vayalapalli, A., Churiwal, M., Rowe, O., Barry, R. L., & Rangaprakash, D. (2025) · Preprints.org · doi:10.20944/preprints202512.2060.v1
An overview of lavender’s effect on cognitive functions and neurodegenerative disorder
Larhlid, I., Boufellous, M., & Aouane, E. M. (2025) · Ecological Engineering & Environmental Technology · doi:10.12912/27197050/215071
“They cannot reverse or halt the underlying neurodegenerative processes and often produce significant side effects that reduce patient adher - ence (Chen et al., 2022).”
Xavier, S. F., M., S. K., Padmanabhan, D., Rajendran, A. K., & Senthilkumar, P. (2025) · Aging Pathobiology and Therapeutics · doi:10.31491/apt.12.194
Recent Advances and Strategies in Drug Repurposing for Alzheimer’s Disease Therapy
Kim, S., Woo, H., Chae, S., & Kim, J. E. (2025) · KSBB Journal · doi:10.7841/ksbbj.2025.40.4.327
Preoperative butyrylcholinesterase activity and risk of postoperative delirium: A meta-analysis
Qiu, Y.-L., Song, C., Huang, C.-W., & Shen, W.-G. (2025) · World Journal of Psychiatry · doi:10.5498/wjp.v16.i1.112450
Review on Role of Cerebrospinal Fluid and Blood Biomarkers in Alzheimer’s Disease Diagnosis
Purna, P. N., Kondrapu, P., Ketha, A., Metri, S., & Bandaru, N. (2025) · Biomedical & Pharmacology Journal · doi:10.13005/bpj/3281
de Morais, F. M. (2024) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Unlocking Neuroprotection: Potassium Channel Openers in Alzheimer's Disease
Kumar, S., Sharma, A., Mehra, G., Kazmi, T., & Sharma, N. (2026) · Current Alzheimer Research · doi:10.2174/0115672050404363251128053608
Soares, E. S. (2023) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
神経細胞における天然食品成分の神経保護作用機構の解明に関する研究
Shi, C. (2025) · Kyushu University Institutional Repository (QIR) (Kyushu University)
The Change in Dementia Presentation During the Past Decades
Jhang, K.-M., Lee, C.-J., & Chen, Y.-C. (2026) · Springer eBooks · doi:10.1007/978-981-95-5222-1_11
Gillani, Q.-U.-A., Mehreen, A., Kharl, H. A. A., Afzal, A., Shakoor, F., Siddique, A., Taqi, M. H., & Farooq, A. B. B. (2026) · IGI Global eBooks · doi:10.4018/979-8-3373-4139-2.ch010
Introduction to Neurodegenerative Diseases
Bele, T. N., Devarshi, S. P., Kamble, R. V., Walvekar, A. P., & Chouhan, P. S. (2026) · IGI Global eBooks · doi:10.4018/979-8-3373-1365-8.ch001
Nanotechnology and Secondary Metabolites: A Synergistic Approach to Combat Neurodegeneration
Kotha, K. K., Chandrakala, A. N., Kumarachari, R. K., Bukke, S. P. N., Sarangapani, P., & Karpagavalli, L. (2026) · IGI Global eBooks · doi:10.4018/979-8-3373-1365-8.ch012
McMackin, R., Price, S., Slator, G. R., Hardiman, O., & Kelly, J. (2026) · Brain Communications · doi:10.1093/braincomms/fcag006
“Reduced cholinergic signalling is a well-established driver of memory decline in Alzheimer’s disease 18-20 and Parkinson’s disease 7,18,19 and is also implicated in cognitive impairment following traumatic brain injury.”
Zhang, X., Ding, W., Guo, C., Chen, X., & Chen, B. (2026) · Behavioural Brain Research · doi:10.1016/j.bbr.2026.116040
Selected African Plants and their Alkaloids in the Management of Alzheimer’s Diseases
Oluyori, A. P., Adewusi, A. T., & Ajanaku, C. O. (2025) · NIPES Journal of Science and Technology Research · doi:10.37933/nipes/7.4.2025.si85
(2025) · Middle East Journal of Applied Sciences · doi:10.36632/mejas/2025.15.2.11
Lateef, U., Junaid, A., Saeed, K., Khalil, H., Tasaddiq, M., & Malik, D. M. (2025) · Journal of medical & health sciences review. · doi:10.65035/w1y9ey43
หลังยาหน่าย, ส. (2026) · KKU Science Journal · doi:10.14456/kkuscij.2026.13
Tabrez, S., Khan, Z., Jabir, N. R., Zaidi, S. K., Mehan, S., Abid, M., Zughaibi, T. A., Alhashmi, M. H., Khoja, R. F., Khan, M., et al. (2026) · Journal of King Saud University - Science · doi:10.25259/jksus_1564_2025
Paez, K., Kopachik, C., Yılmaz, A., Vishweswaraiah, S., Ashrafi, N., Saiyed, N., Monacelli, N., Kerševičiūtė, I., Gordevicius, J., Ruff, S., et al. (2026) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823251387281
Kumar, V., Jangid, K., Devi, B., Mishra, J., Kumar, N., Bhatti, J. S., Kumar, R., & Kumar, V. (2026) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2026.145583
Explorando la Enfermedad de Alzheimer: conocimiento actual y perspectivas futuras
Calvo, A. A. (2024) · UCrea (University of Cantabria)
Güngör, B., Kılıç, B., & Doğruer, D. S. (2025) · EMU Journal of Pharmaceutical Sciences · doi:10.54994/emujpharmsci.1834518
Kanda, A., Mazumder, A., Das, S., Singh, A., & Prabhakar, V. (2026) · Chemistry & Biodiversity · doi:10.1002/cbdv.202502600
Computational Studies toward the Identification of CB2R-M1R Dual Modulators
Isawi, I. H., Al-Zoubi, R. M., Hajjo, R., Obeidat, R. M., AlKhawaldeh, I. H., Kilani, O. M. A., HASAN, M. K., & Morales, P. (2026) · ACS Omega · doi:10.1021/acsomega.5c07866
“20 − 22 Among the muscarinic receptor subtypes, M1R has emerged as a particularly promising route due to its ability to modulate cholinergic neurotransmission.”
Fungi as a Source of Enzyme Inhibitors: Bioprospecting for New Drugs
Saxena, S. (2026) · Mycological Spectrum · doi:10.64993/ms.2.1.2
Nano-Drug Delivery Approaches Against Neurodegenerative Diseases with a Focus on Alzheimer's Disease
Patel, I., Pathak, S., Liu, K. X., Kumar, A., Bellarmine, J. J., & Dhanasekaran, M. (2026) · Springer eBooks · doi:10.1007/978-981-95-6714-0_10
Khan, F., Jain, V., Rai, N., Goyal, J., Khan, R., Yadav, P., Yadav, C., & Arora, J. (2026) · Plant Trends · doi:10.5455/pt.2026.02
Fu, W., Wang, K., Chen, H., Liu, T., Liu, X., Jin, Q., Tan, Z., Dong, W., Liu, W., & Sang, Z.-P. (2026) · RSC Medicinal Chemistry · doi:10.1039/d5md01138h
Güler, E. (2023) · Dspace Repository (Marmara Üniversitesi)
Kurban, M. G., & Enstitüsü, F. B. (2023) · Ağrı İbrahim Çeçen University Institutional Repository
Metadata
- Authors
- Chen, Z.-R., Huang, J.-B., Yang, S.-L., & Hong, F.-F.
- Affiliations
- Nanchang University (CN)
- Experimental Center of Pathogen Biology, Nanchang University, Nanchang 330031, China
- Corresponding author
- Yang, Shu-Long
- Hong, Fen-Fang
- Venue
- Molecules
- Publisher
- MDPI AG
- Published
- 2022-03-10
- Volume
- 27
- Issue
- 6
- Pages
- 1816
- ISSN
- 1420-3049 (ISSN-L)
- PMC
- PMC8949236
- OpenAlex
- W4220945110
- Cited by
- 922
- References
- 141
- Citations by year
- 2026: 256 · 2025: 347 · 2024: 202 · 2023: 87 · 2022: 29
- FWCI
- 22.89
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Molecules (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- National Natural Science Foundation of China (82060661, 81660751, 81660151)
- Jiangxi Provincial Natural Science Foundation of China (20212BAB206092)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Pharmacology (medical) › Cholinesterase and Neurodegenerative Diseases
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, cholinergic neurotransmission, acetylcholine, cholinergic hypothesis, cognitive decline, tau phosphorylation, neuroinflammation, apoptosis, Alzheimer's disease pathogenesis, Alzheimer's disease therapeutics
- MeSH terms
- Acetylcholine, Alzheimer Disease, Humans, Signal Transduction, Cholinergic Agents, Neurodegenerative Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.